Drug delivery to the central nervous system
Despite the rising global incidence of central nervous system (CNS) disorders, CNS drug
development remains challenging, with high costs, long pathways to clinical use and high …
development remains challenging, with high costs, long pathways to clinical use and high …
Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a …
WJ Powers, AA Rabinstein, T Ackerson, OM Adeoye… - Stroke, 2019 - Am Heart Assoc
Background and Purpose—The purpose of these guidelines is to provide an up-to-date
comprehensive set of recommendations in a single document for clinicians caring for adult …
comprehensive set of recommendations in a single document for clinicians caring for adult …
Burden of stroke in Europe: thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years
Background and purpose: Prediction of stroke impact provides essential information for
healthcare planning and priority setting. We aim to estimate 30-year projections of stroke …
healthcare planning and priority setting. We aim to estimate 30-year projections of stroke …
2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association …
WJ Powers, AA Rabinstein, T Ackerson, OM Adeoye… - stroke, 2018 - Am Heart Assoc
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A
Guideline for Healthcare Professionals From the American Heart Association/American Stroke …
Guideline for Healthcare Professionals From the American Heart Association/American Stroke …
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of …
Aim Stroke is the leading cause of disability and death in China. Ischaemic stroke accounts
for about 60%–80% of all strokes. It is of considerable significance to carry out …
for about 60%–80% of all strokes. It is of considerable significance to carry out …
Health benefits of resveratrol: Evidence from clinical studies
AP Singh, R Singh, SS Verma, V Rai… - Medicinal research …, 2019 - Wiley Online Library
Resveratrol is a polyphenolic nutraceutical that exhibits pleiotropic activities in human
subjects. The efficacy, safety, and pharmacokinetics of resveratrol have been documented in …
subjects. The efficacy, safety, and pharmacokinetics of resveratrol have been documented in …
Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials
Background Piperine is a type of amide alkaloid that exhibits pleiotropic properties like
antioxidant, anticancer, anti-inflammatory, antihypertensive, hepatoprotective …
antioxidant, anticancer, anti-inflammatory, antihypertensive, hepatoprotective …
A randomized trial of intraarterial treatment for acute ischemic stroke
OA Berkhemer, PSS Fransen, D Beumer… - … England Journal of …, 2015 - Mass Medical Soc
Background In patients with acute ischemic stroke caused by a proximal intracranial arterial
occlusion, intraarterial treatment is highly effective for emergency revascularization …
occlusion, intraarterial treatment is highly effective for emergency revascularization …
Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the …
Purpose—To critically review and evaluate the science behind individual eligibility criteria
(indication/inclusion and contraindications/exclusion criteria) for intravenous recombinant …
(indication/inclusion and contraindications/exclusion criteria) for intravenous recombinant …
[HTML][HTML] Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of …
Background Alteplase is effective for treatment of acute ischaemic stroke but debate
continues about its use after longer times since stroke onset, in older patients, and among …
continues about its use after longer times since stroke onset, in older patients, and among …